PubMed:25314077 / 87-251 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T2","span":{"begin":0,"end":164},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":164},"obj":"Sentence"}],"text":"Constitutive NF-κB signaling promotes survival in multiple myeloma (MM) and other cancers; however, current NF-κB-targeting strategies lack cancer cell specificity."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":50,"end":66},"obj":"HP_0006775"},{"id":"T2","span":{"begin":82,"end":89},"obj":"HP_0002664"},{"id":"T3","span":{"begin":140,"end":146},"obj":"HP_0002664"}],"text":"Constitutive NF-κB signaling promotes survival in multiple myeloma (MM) and other cancers; however, current NF-κB-targeting strategies lack cancer cell specificity."}